MainIn this measure, the Office of Compliance (OC) is tracking interactions with its stakeholders: regulated firms, trade groups, interest groups, and individual consumers. Congressional and press inquiries also are part of our workload but are tracked by other offices in CDER. Industry and consumer inquiries come into OC through public email addresses, phone calls, and occasionally by letter. Inquiries are answered by OC's staff and analyzed for patterns that may indicate the need for outreach activities or development of guidance. <br>This measure has been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research. </b> Number

Oct 2009125Nov 2009132Dec 2009163Jan 2010203Feb 2010221Mar 2010228Apr 2010217May 2010186Jun 2010206Jul 2010192Aug 2010170Sep 2010166

Oct 2010178Nov 2010168Dec 2010125Jan 2011166Feb 2011230Mar 2011191Apr 2011172May 2011158Jun 2011155Jul 2011187Aug 2011256Sep 2011226http://www.fda.gov/AboutFDA/Transparency/track/ucm206444.htmFDA-TRACK CDER Dashboard